# Shinhan Investment

> Shinhan Investment is a VC fund in Seoul backing Health Care, Software and Biotechnology. See 37 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Seoul, South Korea
- Total investments: 37
- Last investment: Jul 2026
- Lead investor: 24%
- Last updated: Aug 2026
- Website: https://www.shinhaninvest.com/siw/main/front/view.do
- Facebook: https://www.facebook.com/profile.php?id=100057419569096

Shinhan Investment is a VC fund in Seoul focused on Health Care and Software. Shinhan Investment Corp. is a financial services company based out of 여의대로 70, 영등포구, 서울특별시, South Korea.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $1.4M–$23M |
| Series B | $12k–$52M |
| Series C | $26M–$106M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 7 | 19% |
| Software | 6 | 16% |
| Biotechnology | 6 | 16% |
| Manufacturing | 6 | 16% |
| Medical | 5 | 14% |

72 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 14 | 38% |
| Series B | 10 | 27% |
| Series C | 5 | 14% |
| Seed | 3 | 8% |
| Corporate Round | 2 | 5% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 26 | 70% |
| United States | 6 | 16% |
| Bermuda | 1 | 3% |
| Singapore | 1 | 3% |
| United Kingdom | 1 | 3% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Inocras | Inocras Inc. specializes in whole genome sequencing and analytics, focusing on providing insights for personalized care in cancer and rare diseases. Utilizing artificial intelligence, Inocras aims to revolutionize healthcare by enabling precision medicine. The company offers services to patients, healthcare providers, researchers, and partners,seeking to unlock new possibilities in precision health. With a commitment to innovation, Inocras has introduced products like CancerVision and RareVision, designed to enhance diagnosis and treatment strategies through comprehensive genomic analysis. | $20K | Series B | Jul 01, 2026 |  |
| 24X Bermuda | 24X Bermuda operates an electronic brokerage platform that facilitates foreign exchange (FX) spot transactions for institutional users. The company addresses market challenges such as fragmented pools of liquidity and high access fees. It also holds a 'Class T' Cryptocurrency DABA License, allowing it to offer cryptocurrency tradingservices. The platform is designed to introduce both US and non-US institutional clients to efficient and cost-effective trading solutions. |  | Corporate Round | Oct 30, 2025 |  |
| IMBiologics | IMBiologics is a biotechnology company that develops antibody-based drug candidates for diseases such as cancer and immune-related conditions. It conducts research and development using its own platforms to discover new therapeutic molecules. | $29.5M | Series C | Oct 14, 2025 |  |
| Vroong | Mesh Korea is an IT-based logistics startup, which established Korea's first last-mile logistics network and became the primary provider of integrated logistics services with in-house logistics solutions.VROONG, Mesh Korea's logistics brand, creates new value not only by providing delivery services, but also by connecting information.Currently, VROONG provides four services; premium delivery services, 'VROONG Prime', integrated logistics management solution, 'VROONG TMS', premium fresh food delivery services, 'VROONG Fresh', and premium delivery magazine, 'VROONG Collection.'With more than 80 VROONG Stations and 13,000 riders across the nation, VROONG provides faster and more accurate delivery services. | $7.2M | Venture - Series Unknown | Sep 02, 2025 |  |
| Canteen9 | Canteen9 is the producer of supplement products intended to provide a well-balanced diet of essential nutrients for children without excessive intake. The company's product offering includes supplements for eyes, bones, skin, and overall immunity, enabling parents to take care of their children by enhancing their well-being. | $2.2M | Series A | Apr 29, 2025 |  |
| Vroong | Mesh Korea is an IT-based logistics startup, which established Korea's first last-mile logistics network and became the primary provider of integrated logistics services with in-house logistics solutions.VROONG, Mesh Korea's logistics brand, creates new value not only by providing delivery services, but also by connecting information.Currently, VROONG provides four services; premium delivery services, 'VROONG Prime', integrated logistics management solution, 'VROONG TMS', premium fresh food delivery services, 'VROONG Fresh', and premium delivery magazine, 'VROONG Collection.'With more than 80 VROONG Stations and 13,000 riders across the nation, VROONG provides faster and more accurate delivery services. | $20.8M | Venture - Series Unknown | Mar 17, 2025 |  |
| FIRMMIT | FIRMMIT is an ag-tech company that optimizes growth data by securing and analyzing agricultural technology data. | $7.4M | Series B | Oct 04, 2024 |  |
| Bright Machines | Bright Machines is a manufacturing startup that aims to eliminate manual labor from manufacturing electronic devices by combining robots and new software. Its software-defined manufacturing platform helps customers innovate faster to meet the growing demands of a new era of manufacturing.The company was founded by former Autodesk executive, ArmarHanspal, in 2018. | $106M | Series C | Jun 25, 2024 |  |
| B:eat Corp | B: eat is a retail automation platform intended to run a robot-based cafe. |  | Series B | Nov 28, 2023 |  |
| YMX | YMX is a firm that specializes in XR-based industrial metabus platforms, with solutions that address chronic pain points throughout the manufacturing industry's life cycle, from facility building to production and maintenance. | $4M | Series A | Aug 29, 2023 |  |

10 of 37 investments shown.

## Co-investors
- [Korea Investment Partners](https://shizune.co/investors/profile/korea-investment-partners) — VC Fund, 6 deals together
- [Shinhan Capital](https://shizune.co/investors/profile/shinhan-capital) — VC Fund, 5 deals together
- [KB Investment](https://shizune.co/investors/profile/kbinvest) — VC Fund, 3 deals together
- [Korea Investment & Securities](https://shizune.co/investors/profile/korea-investment-securities-d0c5) — VC Fund, 3 deals together
- [Korea Development Bank](https://shizune.co/investors/profile/korean-development-bank) — VC Fund, 3 deals together
- [Mirae Asset Venture Investment](https://shizune.co/investors/profile/mirae-asset-venture-investment) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Health Care Investors in South Korea](https://shizune.co/investors/health-care-investors-south-korea)
- [Health Care VC Funds in South Korea](https://shizune.co/investors/health-care-vc-funds-south-korea)
- [Biotech Investors in South Korea](https://shizune.co/investors/biotech-investors-south-korea)
- [Biotech VC Funds in South Korea](https://shizune.co/investors/biotech-vc-funds-south-korea)
- [Proptech Investors in South Korea](https://shizune.co/investors/proptech-investors-south-korea)
- [Real Estate Investors in South Korea](https://shizune.co/investors/real-estate-investors-south-korea)

## FAQ

### What does Shinhan Investment invest in?

Shinhan Investment invests primarily in Health Care, Software and Biotechnology startups, most often at Series A and Series B stage. Most of the 37 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Shinhan Investment's check size?

Shinhan Investment typically joins rounds of $1.4M–$23M at Series A, $12k–$52M at Series B and $26M–$106M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Shinhan Investment participates in.

### When did Shinhan Investment last invest?

The most recent investment recorded for Shinhan Investment closed in Jul 2026. Shizune tracks 37 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co